The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study
Public ClinicalTrials.gov record NCT00547482. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this research study is to investigate whether the TANTALUS II System is effective in improving glycemic (blood sugar) control in subjects who have type 2 diabetes (high blood sugar) and are overweight. The research will also evaluate the impact on weight loss and will study other health conditions related to obesity. This research study involves an experimental system. The experimental system is the TANTALUS System, which consists of the implantable portion that includes the implantable pulse generator (IPG) and three pairs of implantable leads. There are also three external parts (items that are used outside your body): the programmer, the charger, and the Patient Wand.
Study identification
- NCT ID
- NCT00547482
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2007 (Type not available)
- Primary completion
- Nov 2009 (Actual)
- Completion
- Nov 2009 (Actual)
- Last update posted
- Dec 16, 2010
2007 – 2009
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scripps Clinic Del Mar | La Jolla / San Diego | California | 92130 | — |
| Cedars Sinai | Los Angeles | California | 90048 | — |
| University of Colorado at Denver Health Sciences Center | Denver | Colorado | 80262 | — |
| Washington University School of Medicine in St. Louis | St Louis | Missouri | 63110 | — |
| Kaleida Health, Diabetes-Endocrinology Center of Western New York | Buffalo | New York | 14209 | — |
| Comprehensive Weight Control Program Cornell Medical Center | New York | New York | 10021 | — |
| Mt. Sinai School of Medicine | New York | New York | 10029-6574 | — |
| University of Pennsylvania | Pennsylvania | Pennsylvania | 19104-3309 | — |
| Vanderbilt University School of Medicine | Nashville | Tennessee | 37232 | — |
| Diabetes and Glandular Disease Clinic (DGD) | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00547482, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2010 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00547482 live on ClinicalTrials.gov.